First in Human Study of EMB-07 in Locally Advanced/Metastatic Solid Tumors or Relapse/Refractory Lymphoma

NCT05607498 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced/Metastatic Solid Tumors
Relapse/Refractory Lymphoma

Interventions

DRUG: EMB07

Sponsor

EpimAb Biotherapeutics (Suzhou)Co., Ltd.